Previous Article | Next Article ![]()
J. Virol., Mar 1997, 2495-2499, Vol 71, No. 3
M Ma and A Nath
We measured the cellular uptake of 125I-labeled full-length Tat (amino
acids 1 to 86) (125I-Tat(1-86)) and 125I-Tat(1-72) (first exon) in human
fetal astrocytes, neuroblastoma cells, and human fetal neurons and
demonstrated that the uptake of 125I-Tat(1-72) without the second exon was
much lower than that of 125I-Tat(1-86) (P < 0.01). This suggests an
important role for the C-terminal region of Tat for its cellular uptake.
125I-Tat uptake could be inhibited by dextran sulfate and competitively
inhibited by unlabeled Tat but not by overlapping 15- mer peptides,
suggesting that Tat internalization is charge and conformationally
dependent. Interestingly, one of 15-mer peptides, Tat(28-42), greatly
enhanced 125I-Tat uptake. These findings are important for understanding
the neuropathogenesis of human immunodeficiency virus type 1 infection and
in the potential application of Tat for drug delivery to cells.
Copyright © 1997, American Society for Microbiology
Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells
Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»